BOULDER, Colo., Jan. 27, 2016 -- CBDRx, the premier organic hemp company located in Colorado, is extremely pleased to announce that it has received USDA Organic Certification for its entire hemp crop. CBDRx is one of the first companies in the U.S. to have the processes, documentation, and transparency necessary to achieve this groundbreaking organic certification.
CBDRx specializes in the development, cultivation, processing, and wholesale distribution of hemp-based CBD products, which may be used by the wellness, nutraceutical, and pharmaceutical industries. CBDRx grows its USDA Certified Organic hemp in Colorado from proprietary high-CBD, low-THC, broad-spectrum hemp strains that yield high-quality cannabinoid oils. CBDRx follows organic protocols that use no pesticides. CBDRx processes its hemp into its CBDRx Prime Organics (SM) CBD oils using state-of-the-art extraction laboratories.
Marc Brannigan, CEO of CBDRx, stated: "The CBD industry is plagued by products from unidentifiable overseas sources making dubious, unverifiable, and false claims. We are understandably proud to be one of the first companies in the United States offering organic CBD products with the high quality, consistency, and transparency that this industry demands, and which CBDRx's domestically-grown USDA Certified Organic hemp can deliver.”
CBDRx recently harvested its 120-acre crop of USDA Certified Organic hemp, and is supplying the very highest quality hemp flower and whole-plant, full spectrum ethanol, Co2, and lipid extractions.
To contact us or to learn more about CBDRx, please visit www.cbdrx.com.
Media Contact: [email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



